EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Double‐Blind Placebo Challenge Confirmation of Diphenhydramine Allergy

Ruchi Patel, Aleena Mahmood, Eugenio Capitle

Clinical Case Reports · 2026-04 · 14 (4)

DOI: 10.1002/ccr3.72377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 23.03.2026. Verfasst von Ruchi Patel und 2 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diphenhydramine, a first‐generation H 1 –antihistamine commonly used for allergic symptom relief and infusion premedication, rarely causes true systemic hypersensitivity. When suspected reactions are mild and subjective—particularly in anxious patients—objective confirmation is essential. In our case, a 52‐year‐old woman with immune thrombocytopenia, common variable immunodeficiency on monthly IVIG, type 2 diabetes, and anxiety reported two pruritic episodes (tongue and truncal itching) following diphenhydramine premedication for rituximab and IVIG infusions. We initially staged open oral challenge (6.25 mg then 50 mg diphenhydramine); pruritus occurred 20 min after the first dose and 30 min after the second (relieved with loratadine). The next day, a double‐blind, placebo‐controlled intravenous challenge was conducted using two identically masked syringes (0.5 mL saline vs. 25 mg diphenhydramine), separated by a 2‐h interval under continuous monitoring. The patient had no symptoms after placebo infusion. Within minutes of the active diphenhydramine infusion, she experienced reproducible throat itchiness without objective cutaneous or systemic signs. Clinicians should consider a double‐blind, placebo‐controlled challenge in confirming immediate (type I) hypersensitivity to medication particularly when the reaction is rare or when nocebo effects may confound history.

Zitieren

APA

Patel, R., Mahmood, A., & Capitle, E. (2026). Double‐Blind Placebo Challenge Confirmation of Diphenhydramine Allergy. Clinical Case Reports, 14(4). https://doi.org/10.1002/ccr3.72377

Vancouver

Patel R, Mahmood A, Capitle E. Double‐Blind Placebo Challenge Confirmation of Diphenhydramine Allergy. Clinical Case Reports. 2026;14(4). doi:10.1002/ccr3.72377

BibTeX
@article{Patel2026,
  author = {Patel, Ruchi and Mahmood, Aleena and Capitle, Eugenio},
  title = {Double‐Blind Placebo Challenge Confirmation of Diphenhydramine Allergy},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/ccr3.72377}
}
Kostenlos starten →